FDA Heralds The End Of Switching Studies For Biosimilar Interchangeability

Guidance Suggests Analytical And Clinical Data Can Be Sufficient To Support Application

 
• By Dave Wallace
  
Red on off switch
The FDA is switching off the requirement for switching studies • Source: Shutterstock

More from Biosimilars

More from Products